Byung-Kwang (BK) YOO, MD, MSc, PhD
(updated June 5, 2020)
Email: 
-- Please type by your own.
Citizenship: U.S. citizen
EDUCATION
| 2002 | Doctor of Philosophy (PhD), Health Policy and Management (Concentration: Health Economics), Johns Hopkins University, Baltimore, MD |
| 1997 | Master of Science (MSc), Health Policy and Management Harvard University School of Public Health, Boston, MA |
| 1993 | Doctor of Medicine (MD), Hokkaido University School of Medicine, Sapporo, Japan |
PROFESSIONAL EXPERIENCE
| 4/2020-present | Professor, School of Health Innovation, Kanagawa University of Human Services, Kanagawa, Japan |
| 2011-3/2020 | Associate Professor (tenured), Department of Public Health Sciences, University of California (UC) Davis, School of Medicine, Davis, CA, U.S.A. |
| 2006-8/2011 | Assistant Professor (tenure track), Division of Health Policy and Outcomes Research, Department of Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY, U.S.A. |
| 2004- 2006 |
Health Economist/Prevention Effectiveness Fellow, Centers for Disease Control and Prevention (CDC), Atlanta, GA |
| 9/2004-present | Adjunct Associate (formal affiliation without salary), Center for Health Policy, Stanford University, Palo Alto, CA, U.S.A. |
| 2002- 2004 |
Research Associate (post-doctoral fellow), Center for Health Policy, Stanford University, Palo Alto, CA, U.S.A. |
| 1993- 1995 |
Medical Resident, Dept. of Orthopedics and Anesthesia, Osaka National Hospital, Japan |
SELECTED RESEARCH ACTIVITIES COMPLETED GRANTS/CONTRACTS (Served as Principal Investigator)
| 2017- 2018 |
California State Department of Public Health (CDPH), Cardiovascular Disease (CVD) Contract (Economic evaluations of interventions to prevent CVD and diabetes) |
| 2013- 2015 |
National Institutes of Health (NIH), Factors Affecting Disparities in Influenza Vaccination among Medicare Elderly (Grant #: R03AG042646) |
| 2007- 2012 |
National Institute of Health (NIH), Effects of Individual Behavioral Responses on Benefits of Influenza Vaccination (Grant #: 1K25AI073915) |
| 2001- 2002 |
Centers for Medicare and Medicaid Services (Health Services Dissertation Research), The Determinants of Influenza Vaccination Timing (Grant #:30P 912953) |
SELECTED SERVICES Public Health Conference Support Grant Cycle A Review Panel (Program Announcement (PA) 05002), US Department of Health and Human Services, Centers for Disease Control and Prevention (CDC)/ Agency for Toxic Substances and Disease Registry (ATSDR), 2005 Role: Proposal Reviewer California State Legislature Contract 2012-2017 “California Health Benefits Review Program (CHBRP) - Cost Impact Analysis” Amount: $2,000,000 per year Principal Investigator: Dr. Todd Gilmer (UCSD) for 2012-13 and Dr. Ninez Ponce (UCLA) for 2013-2017 University of California, Office of the President (UCOP) Role: Member of the Cost Team as Health Economist (July 2012-2017), Content expert (March-April 2012) (*) The detailed activities of the CHBRP are attached at the bottom of this text. Proposal reviewer for Swiss National Science Foundation: July 2014, July 2015 The National Institutes of Health (NIH) Center for Scientific Review (CSR):
- Reviewer, National Cancer Institute: Minutes of the National Cancer Institute Special Emphasis Panel (ZCA1 SRO-S 01 1) (April 1-3, 2019, Bethesda, MD)
- Reviewer, Health Services Organization and Delivery Study Section (HSOD) (September 24-25, 2018, Chicago, IL)
- Reviewer, Health Services Organization and Delivery Study Section (HSOD) (February 20-21, 2018, Washington D.C.)
- Reviewer, Health Services Organization and Delivery Study Section (HSOD) (September 25-26, 2017, Chicago, IL)
- Reviewer, Health Services Organization and Delivery Study Section (HSOD) (June 21, 2017, Washington D.C.)
(*) Report to California State Legislature under California Health Benefits Review Program (CHBRP) The CHBRP responds to requests from the State Legislature to provide independent analysis of the medical, financial, and public health impacts of proposed health insurance benefit mandates and repeals. A small analytic staff in the University of California's Office of the President works with a task force of faculty from several campuses of the University of California, as well as actuarial consultants to complete each analysis during a 60-day period, usually before the Legislature begins formal consideration of a mandate bill. A National Advisory Council, made up of experts from outside the state of California and designed to provide balanced representation among groups with an interest in health insurance benefit mandates, reviews draft studies to assure their quality before they are transmitted to the Legislature. Each report summarizes sound scientific evidence relevant to the proposed mandate but does not make recommendations, deferring policy decision-making to the Legislature. The State funds this work through a small annual assessment of health plans and insurers in California. As a health economist, I am in charge of the “Cost Impact Analysis” component of the project, conducting two major types of analysis regarding proposed benefit mandate legislation: (1) the present (baseline) coverage of the benefit, existing utilization, and costs of the benefit; and (2) projected (post-mandate) changes in coverage, utilization, and costs in the year after the enactment of a proposed mandate. I was a cost-section lead author of the bill analyses below.
- Analysis of Senate Bill 1053: Health Care Coverage: Contraceptives (April 20, 2014; http://analyses.chbrp.com/document/view.php?id=907)
- Analysis of Assembly Bill 219: Health Care Coverage: Cancer Treatment (April 4, 2013; http://analyses.chbrp.com/document/view.php?id=781)
- Analysis of Assembly Bill 912: Health Care Coverage: Fertility Preservation (April 25, 2013; http://analyses.chbrp.com/document/view.php?id=833)
Other